Health Technology Assessments

Health Technology Assessments (HTAs) are a comprehensive systematic review and critical analysis of available evidence for A SINGLE medical technology for which there are several published clinical trials and a substantial body of evidence. This report details an entire technology class for which there are one or more indications or patient populations in use.

Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.

Lasmiditan (Reyvow) for Acute Migraine Treatment

Focus of the Report: This report focuses on the efficacy and safety of the 5-hydroxytryptamine 1F (5-HT1F) receptor agonist lasmiditan (Reyvow) for acute treatment of migraines.

Technology Description: The 5-HT1F receptors are…

Ubrogepant (Ubrelvy) for Acute Migraine Treatment

Focus of the Report: This report focuses on the efficacy and safety of the calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant (Ubrelvy) for acute treatment of migraines.

Technology Description: Ubrogepant is approved for the acute treatment of migraine. Ubrogepant is a C…

Artificial Pancreas with the t:slim X2 for the Management of Diabetes Mellitus

Focus of the Report: This health technology assessment focuses on the use of t:slim X2 Insulin Pump and Dexcom 6 continuous glucose monitoring (CGM) with Control-IQ closed-loop control (CLC) or Basal-IQ predictive low-glucose suspend (PLGS) technology for the management of diabetes mellitus (DM).

Lee Silverman Voice Treatment (LSVT) LOUD for Speech and Voice Problems in Parkinson Disease

Focus of the Report: This report focuses on Lee Silverman Voice Treatment (LSVT) LOUD for the treatment of patients with speech and voice problems resulting from Parkinson disease (PD).

Technology Description: LSVT LOUD is an intensive voice therapy regimen that requires high patient e…

Liposuction for the Reductive Surgical Treatment of Lymphedema

Focus of the Report: This report focuses on the use of liposuction (also called suction-assisted lipectomy) for the surgical treatment of patients with lymphedema.

Technology Description: Liposuction is a reductive, minimally invasive, surgical procedure used to remove hypertrophied ad…